Drug resistant shigellosis in south India.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004405:Dysentery, Bacillary / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D007194:India; D009268:Nalidixic Acid / Q000627:therapeutic use; D011815:R Factors / Q000187:drug effects*; D012760:Shigella / Q000187:drug effects*; D013411:Sulfadiazine / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013411:Sulfadiazine; D009268:Nalidixic Acid; D014295:Trimethoprim